ClinicalTrials.gg
CompletedNCT07654608Updated Jul 27, 2026

Electromyographic Response to Blood Flow Restriction Exercise in Healthy Adults

An interventional study of Bilateral low-load knee extension exercise protocol and Pneumatic blood flow restriction cuff in Electromyographic Response to Blood Flow Restriction Exercise in Healthy Adults, sponsored by Universidad de Extremadura. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-27.

Sponsored by Universidad de Extremadura · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Mar 2026, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This pilot randomized contralateral within-participant study evaluated the immediate neuromuscular response to low-load knee extension exercise performed with and without blood flow restriction in healthy young adults.

Participants were randomized in a 1:1 ratio to one of two limb-allocation groups: blood flow restriction applied to the dominant limb or blood flow restriction applied to the non-dominant limb. In each participant, the contralateral limb completed the same exercise protocol without blood flow restriction. Therefore, all participants were assessed under both experimental conditions.

Both limb-specific conditions were completed during the same experimental session. The order of the blood flow restriction and non-blood flow restriction conditions was randomized for each participant, with a 10-minute rest period between conditions.

Blood flow restriction was applied using a pneumatic cuff positioned on the proximal thigh. Cuff pressure was individualized and set at 80% of the arterial occlusion pressure measured for the corresponding limb. Participants completed the same standardized low-load knee extension protocol under both conditions.

Surface electromyography was used to record vastus lateralis activity from each assessed limb during the exercise protocol. Muscle activity was primarily evaluated using root mean square amplitude normalized to the pre-exercise maximal voluntary isometric contraction recorded from the corresponding limb. Root mean square amplitude during maximal voluntary isometric contraction trials was also recorded before and immediately after each condition.

The study aimed to compare the electromyographic response between the blood flow restriction and non-blood flow restriction conditions and to determine whether this response differed according to whether blood flow restriction was applied to the dominant or non-dominant limb.

02

Conditions studied

  • Electromyographic Response to Blood Flow Restriction Exercise in Healthy Adults
03

In context

Lead sponsor

Universidad de Extremadura is the lead sponsor of 39 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 65 years.
  • Healthy adults.
  • Absence of active pain or musculoskeletal injury in the lower limbs at the time of assessment.
  • Ability to understand the study procedures.
  • Voluntary agreement to participate and provision of written .

Exclusion criteria

Exclusion Criteria:

  • History of neuromuscular disease.
  • History of cardiovascular disease.
  • History of peripheral vascular disease.
  • History of thromboembolic events.
  • Uncontrolled hypertension.
  • Skin lesions or skin conditions preventing placement of the blood flow restriction cuff or surface electromyography electrodes.
  • Recent lower limb surgery.
  • Pregnancy.
  • Any other to blood flow restriction exercise.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Experimental: BFR allocated to the dominant limb

    Participants received blood flow restriction on the dominant limb, while the contralateral non-dominant limb completed the same low-load knee extension protocol without blood flow restriction. Both limb-specific conditions were performed during the same experimental session in randomized order, with a 10-minute rest period between conditions. Blood flow restriction pressure was individualized and set at 80% of the arterial occlusion pressure of the corresponding limb. Vastus lateralis surface electromyography was recorded under both conditions.

    Procedure: Bilateral low-load knee extension exercise protocol · Device: Pneumatic blood flow restriction cuff

  • Experimental
    Experimental: BFR allocated to the non-dominant limb

    Participants received blood flow restriction on the non-dominant limb, while the contralateral dominant limb completed the same low-load knee extension protocol without blood flow restriction. Both limb-specific conditions were performed during the same experimental session in randomized order, with a 10-minute rest period between conditions. Blood flow restriction pressure was individualized and set at 80% of the arterial occlusion pressure of the corresponding limb. Vastus lateralis surface electromyography was recorded under both conditions.

    Procedure: Bilateral low-load knee extension exercise protocol · Device: Pneumatic blood flow restriction cuff

Interventions

  • ProcedureBilateral low-load knee extension exercise protocol

    Each participant completed the low-load knee extension exercise protocol separately with both lower limbs. Under each condition, the protocol comprised 75 repetitions distributed across four sets of 30, 15, 15, and 15 repetitions, with 30 seconds of rest between sets. One limb performed the protocol with blood flow restriction and the contralateral limb performed it without blood flow restriction. Condition order was randomized, and a 10-minute rest period was provided between the two limb-specific conditions. Vastus lateralis surface electromyography was recorded continuously during each protocol.

  • DevicePneumatic blood flow restriction cuff

    A pneumatic cuff was placed on the proximal thigh of the limb randomized to the blood flow restriction condition and inflated to 80% of the individualized arterial occlusion pressure during the low-load knee extension protocol. The cuff was not applied to the contralateral limb, which completed the same protocol under the non-blood flow restriction condition. The cuff was fully deflated and removed after completion of the blood flow restriction condition.

06

What researchers measure

Primary outcomes

  1. Vastus Lateralis Electromyographic Amplitude Normalized to Maximal Voluntary Isometric Contraction

    Surface electromyographic activity of the vastus lateralis was assessed during the low-load knee extension exercise protocol. The root mean square amplitude was normalized to the maximal voluntary isometric contraction recorded before exercise and expressed as percentage of maximal voluntary isometric contraction (%MVIC). Measurements were extracted at predefined time points across the four exercise sets in both experimental conditions.

    Time frame: During the exercise protocol, within a single experimental session.

07

Study locations

1 site
  • University of Extremadura
    Badajoz, Badajoz 06006, Spain
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2026 to primary completion in Apr 2026, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2026
First posted
Jun 17, 2026
StartActual
Mar 3, 2026
Primary completionActual
Apr 15, 2026
CompletionActual
Apr 15, 2026
Last update
Jul 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07654608
Lead sponsor
Universidad de Extremadura
Responsible party
Carlos Fernández-Morales (Clinical Professor, Universidad de Extremadura) — Principal investigator
First posted
Jun 17, 2026
Start date
Mar 3, 2026
Primary completion
Apr 15, 2026
Completion
Apr 15, 2026
Last update
Jul 27, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion